Panacea Biotec
PANACEANew Delhi, India· Est.
India‑based pharma delivering generics, biosimilars, and novel oncology drugs with a strong formulation platform.
Is this your company? Claim your profile to update info and connect with investors.
Claim profileAI Company Overview
India‑based pharma delivering generics, biosimilars, and novel oncology drugs with a strong formulation platform.
OncologyCardiologyInfectious DiseasesVaccinesNeurology
Technology Platform
Integrated API synthesis, advanced formulation, and biosimilar development platform combining proprietary cell line and analytical comparability technologies.
Opportunities
Expansion into regulated biosimilar markets and commercialization of late‑stage oncology candidates could drive premium revenue growth.
Risk Factors
Regulatory delays, intense competition from global generics and biosimilar players, and potential pipeline attrition pose significant risks.
Competitive Landscape
Competes with Sun Pharma, Cipla, Dr. Reddy's, and Biocon; differentiation stems from its integrated biosimilar platform and emerging oncology pipeline.